Barclays lowered the firm’s price target on IFF (IFF) to $90 from $99 and keeps an Equal Weight rating on the shares. IFF followed a similar pattern to its peers with stronger Q3 results and “cautious optimism around customer order patterns into year-end, and in response, IFF stock sold off as the market looks out to growth normalizing in 2025, also similar to peers, the analyst tells investors. While implied Q4 adjusted EBITDA is below consensus estimates, the firm views this as the company being “appropriately conservative” and views the market’s reaction to IFF results today as “overdone,” the analyst added.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter